EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole‐Based Hydrazide Derivatives as Potential Anti‐Tuberculosis Agents

Vivek Sharma, Arun Sharma, Ruchi Poria iD, Pardeep Kumar iD

Chemical Biology & Drug Design · 2026-09 · 108 (3)

DOI: 10.1111/cbdd.70405 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2026-09-19. Written by Vivek Sharma and 3 co-authors. Institution: Department of Chemistry U.G.C. Centre of Advanced Studies, Guru Nanak Dev University, Amritsar, India. Major MEDLINE topics: Antitubercular Agents, Mycobacterium tuberculosis, Drug Design, Thiazoles. Cited 1 times so far (Crossref); 53 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

A series of novel benzisothiazole‐based hydrazide derivatives was rationally designed, synthesized, and evaluated for their antitubercular activity. Among the synthesized compounds, derivative 8k emerged as the most potent candidate, exhibiting a minimum inhibitory concentration (MIC) of 0.25 μg/mL, along with a high selectivity index (SI) of 42 and confirmed bactericidal activity. To gain preliminary insights into its possible mechanism of action, compound 8k was subjected to molecular docking and 100 ns molecular dynamics simulations, using enoyl‐acyl carrier protein reductase (InhA) as the proposed molecular target. The computational studies revealed favorable binding interactions and a relatively stable protein–ligand complex, suggesting InhA as a potential molecular target. However, experimental target‐validation studies are required to confirm direct InhA inhibition and establish the proposed mechanism of action. Furthermore, in silico ADMET predictions indicated favorable pharmacokinetic characteristics and drug‐likeness properties for the lead compound. Collectively, these findings highlight the potential of benzisothiazole‐based hydrazide derivatives as promising scaffolds for the development of new antitubercular agents.

Subjects

MeSH terms (MEDLINE)

Antitubercular AgentsMycobacterium tuberculosisDrug DesignThiazolesHydrazinesMolecular Docking SimulationMicrobial Sensitivity TestsBacterial ProteinsMolecular Dynamics SimulationOxidoreductasesBinding Sites

Author keywords

Benzisothiazoledrug resistancehydrazidein‐siliico studiestuberculosis

Substances

Antitubercular AgentsThiazolesHydrazinesBacterial ProteinsInhA protein, MycobacteriumOxidoreductases

Authors and institutions

  • Department of Chemistry U.G.C. Centre of Advanced Studies, Guru Nanak Dev University, Amritsar, India.
  • Swami Dayanand Post Graduate Institute of Pharmaceutical Sciences Rohtak, Pandit Bhagwat Dayal Sharma University of Health and Sciences, Rohtak, Haryana, India.

ORCID profiles: Ruchi Poria, Pardeep Kumar

Cite

APA

Sharma, V., Sharma, A., Poria, R., & Kumar, P. (2026). Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole‐Based Hydrazide Derivatives as Potential Anti‐Tuberculosis Agents. Chemical Biology & Drug Design, 108(3). https://doi.org/10.1111/cbdd.70405

Vancouver

Sharma V, Sharma A, Poria R, Kumar P. Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole‐Based Hydrazide Derivatives as Potential Anti‐Tuberculosis Agents. Chemical Biology & Drug Design. 2026;108(3). doi:10.1111/cbdd.70405

BibTeX
@article{Sharma2026,
  author = {Sharma, Vivek and Sharma, Arun and Poria, Ruchi and Kumar, Pardeep},
  title = {Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole‐Based Hydrazide Derivatives as Potential Anti‐Tuberculosis Agents},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {108},
  number = {3},
  doi = {10.1111/cbdd.70405}
}
Start for free →